Search results
SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer
FOX 5 San Diego· 9 hours agoSN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track Designation for small cell lung cancer (SCLC) for SNB ...
FDA fast track status granted to iECURE neonatal OTC deficiency treatment
Pharmaceutical Technology via Yahoo Finance· 2 days agoThe therapeutic benefits of ECUR-506 have been recognised previously, with the FDA awarding it rare...
Avidity Biosciences Receives FDA Breakthrough Therapy Designation for Delpacibart Etedesiran (AOC...
FOX40 Sacramento· 2 days agoFood and Drug Administration (FDA) has granted Breakthrough Therapy designation to delpacibart etedesiran (AOC 1001), the company's lead ...
Regenex Bio eyes FDA meeting to confirm pivotal DMD trial
Clinical Trials Arena via Yahoo Finance· 1 day agoInitial strength and functional assessment data for both dose levels of the AFFINITY DUCHENNE trial...
Shionogi secures licence for Maze’s Pompe disease treatment
Pharmaceutical Technology via Yahoo Finance· 2 hours agoIts potential extends to both a standalone treatment and an adjunctive therapy alongside enzyme...
STEALTH BIOTHERAPEUTICS' BARTH SYNDROME NDA RECEIVES PRIORITY REVIEW DESIGNATION
KOIN News 6 Portland· 3 days agoFood and Drug Administration ("FDA") has now determined that its New Drug Application ("NDA") for elamipretide for the treatment of Barth ...
Jaguar Health Announces Submission of Clinical Trial Applications for Crofelemer for the Rare...
Digital Journal· 22 hours agoJaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA ...
Lisata Therapeutics reports strong 1Q performance, cash to support operations into 2026
Proactive Investors· 20 hours agoCEO David Mazzo told shareholders that the company is off to a strong start to 2024, with Phase 2b...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 1 hour agoSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an ...
Biotech CEL-SCI gets FDA go-ahead to conduct investigational cancer immunotherapy study - Maryland...
The Daily Record· 2 days agoThe project will study the drug’s effectiveness in newly diagnosed advanced primary head and neck cancer patients with no lymph node involvement, determined via PET scan, ...